{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T14:21:03Z","timestamp":1779373263854,"version":"3.53.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2010,1,5]],"date-time":"2010-01-05T00:00:00Z","timestamp":1262649600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1007\/s00535-009-0185-9","type":"journal-article","created":{"date-parts":[[2010,1,3]],"date-time":"2010-01-03T20:05:10Z","timestamp":1262549110000},"page":"554-559","source":"Crossref","is-referenced-by-count":13,"title":["Therapeutic factors considered according to the preoperative splenic volume for a prolonged increase in platelet count after partial splenic embolization for liver cirrhosis"],"prefix":"10.1007","volume":"45","author":[{"given":"Hiromitsu","family":"Hayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Beppu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutoshi","family":"Okabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiro","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohisa","family":"Okabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takatoshi","family":"Ishiko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,1,5]]},"reference":[{"key":"185_CR1","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1002\/hep.1840220611","volume":"22","author":"H Noguchi","year":"1995","unstructured":"Noguchi H, Hirai K, Aoki Y, Sakata K, Tanikawa K. Changes in platelet kinetics after a partial splenic arterial embolization in cirrhotic patients with hypersplenism. Hepatology. 1995;22:1682\u20138.","journal-title":"Hepatology"},{"key":"185_CR2","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/hep.1840180214","volume":"18","author":"B Sangro","year":"1993","unstructured":"Sangro B, Bilbao I, Herrero I, Corella C, Longo J, Beloqui O, et al. Partial splenic embolization for the treatment of hypersplenism in cirrhosis. Hepatology. 1993;18:309\u201314.","journal-title":"Hepatology"},{"key":"185_CR3","first-page":"694","volume":"96","author":"MF Mozes","year":"1984","unstructured":"Mozes MF, Spigos DG, Pollak R, Abejo R, Pavel DG, Tan WS, et al. Partial splenic embolization, an alternative to splenectomy\u2014results of a prospective, randomized study. Surgery. 1984;96:694\u2013702.","journal-title":"Surgery"},{"key":"185_CR4","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00042737-200502000-00008","volume":"17","author":"G N\u2019Kontchou","year":"2005","unstructured":"N\u2019Kontchou G, Seror O, Bourcier V, Mohand D, Ajavon Y, Castera L, et al. Partial splenic embolization in patients with cirrhosis: efficacy, tolerance and long-term outcome in 32 patients. Eur J Gastroenterol Hepatol. 2005;17:179\u201384.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"185_CR5","first-page":"105","volume":"33","author":"K Hirai","year":"1986","unstructured":"Hirai K, Kawazoe Y, Yamashita K, Kumagai M, Tanaka M, Sakai T, et al. Transcatheter partial splenic arterial embolization in patients with hypersplenism: a clinical evaluation as supporting therapy for hepatocellular carcinoma and liver cirrhosis. Hepatogastroenterology. 1986;33:105\u20138.","journal-title":"Hepatogastroenterology"},{"key":"185_CR6","first-page":"1445","volume":"49","author":"T Tajiri","year":"2002","unstructured":"Tajiri T, Onda M, Yoshida H, Mamada Y, Taniai N, Kumazaki T. Long-term hematological and biochemical effects of partial splenic embolization in hepatic cirrhosis. Hepatogastroenterology. 2002;49:1445\u20138.","journal-title":"Hepatogastroenterology"},{"key":"185_CR7","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1872-034X.2007.00302.x","volume":"38","author":"H Yoshida","year":"2008","unstructured":"Yoshida H, Mamada Y, Taniai N, Tajiri T. Partial splenic embolization. Hepatol Res. 2008;38:225\u201333.","journal-title":"Hepatol Res"},{"key":"185_CR8","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1097\/00042737-200511000-00002","volume":"17","author":"JR Foruny","year":"2005","unstructured":"Foruny JR, Blazquez J, Moreno A, Barcena R, Gil-Grande L, Quereda C, et al. Safe use of pegylated interferon\/ribavirin in hepatitis C virus cirrhotic patients with hypersplenism after partial splenic embolization. Eur J Gastroenterol Hepatol. 2005;17:1157\u201364.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"185_CR9","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1097\/00042737-200511000-00001","volume":"17","author":"B Palsson","year":"2005","unstructured":"Palsson B, Verbaan H. Partial splenic embolization as pretreatment for antiviral therapy in hepatitis C virus infection. Eur J Gastroenterol Hepatol. 2005;17:1153\u20135.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"185_CR10","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1432-2277.2006.00263.x","volume":"19","author":"N Sohara","year":"2006","unstructured":"Sohara N, Takagi H, Kakizaki S, Sato K, Mori M. The use of partial splenic artery embolization made it possible to administer interferon and ribavirin therapy in a liver transplant patient with fibrosing cholestatic hepatitis C complicated with thrombocytopenia. Transpl Int. 2006;19:255\u20137.","journal-title":"Transpl Int"},{"key":"185_CR11","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1111\/j.1440-1746.2007.05090.x","volume":"22","author":"H Hayashi","year":"2007","unstructured":"Hayashi H, Beppu T, Masuda T, Mizumoto T, Takahashi M, Ishiko T, et al. Predictive factors for platelet increase after partial splenic embolization in liver cirrhosis patients. J Gastroenterol Hepatol. 2007;22:1638\u201342.","journal-title":"J Gastroenterol Hepatol"},{"key":"185_CR12","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/bjs.6081","volume":"95","author":"H Hayashi","year":"2008","unstructured":"Hayashi H, Beppu T, Okabe K, Masuda T, Okabe H, Baba H. Risk factors for complications after partial splenic embolization for liver cirrhosis. Br J Surg. 2008;95:744\u201350.","journal-title":"Br J Surg"},{"key":"185_CR13","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/00000658-198211000-00003","volume":"196","author":"A Alwmark","year":"1982","unstructured":"Alwmark A, Bengmark S, Gullstrand P, Joelsson B, Lunderquist A, Owman T. Evaluation of splenic embolization in patients with portal hypertension and hypersplenism. Ann Surg. 1982;196:518\u201324.","journal-title":"Ann Surg"},{"key":"185_CR14","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1056\/NEJMoa0807650","volume":"360","author":"C Hezode","year":"2009","unstructured":"Hezode C, Forestier N, Dusheiko G, Ferenci P, Pol S, Goeser T, et al. Telaprevir and peginterferon with or without ribavirin for chronic HCV infection. N Engl J Med. 2009;360:1839\u201350.","journal-title":"N Engl J Med"},{"key":"185_CR15","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1056\/NEJMoa0806104","volume":"360","author":"JG McHutchison","year":"2009","unstructured":"McHutchison JG, Everson GT, Gordon SC, Jacobson IM, Sulkowski M, Kauffman R, et al. Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection. N Engl J Med. 2009;360:1827\u201338.","journal-title":"N Engl J Med"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-009-0185-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-009-0185-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-009-0185-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T22:37:47Z","timestamp":1559083067000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-009-0185-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,5]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["185"],"URL":"https:\/\/doi.org\/10.1007\/s00535-009-0185-9","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,5]]}}}